EGRX - Eagle Pharmaceuticals Non-GAAP EPS of $1.56 misses by $1.80 revenue of $74.1M misses by $42.79M August, 09 2022 06:52 AM Eagle Pharmaceuticals Inc. Eagle Pharmaceuticals press release ( NASDAQ: EGRX ): Q2 Non-GAAP EPS of $1.56 misses by $1.80 . Revenue of $74.1M (+54.0% Y/Y) misses by $42.79M . For further details see: Eagle Pharmaceuticals Non-GAAP EPS of $1.56 misses by $1.80, revenue of $74.1M misses by $42.79M